Antibodies to streptococcal extracellular products were detected in rabbit sera by passive hemagglutination tests as early as 1 week after intravenous injection of live group A streptococci (strain C203S). Using these antibodies in immunoadsorbent columns, we prepared an antigenic fraction from crude concentrates of streptococcal extracellular products. The specific activity of this fraction in sensitizing glutaraldehyde-treated erythrocytes for passive hemagglutination tests and in absorbing passive hemagglutination antibodies from immune sera was increased by 80-fold and at least 24-fold, respectively, as compared with crude extracellular products. The fraction has been found to contain at least three serologically active antigens, which are of considerable interest because: (i) they gave rise to early and consistent immune responses both in humans and in experimental animals; (ii) they appear so far to be produced only by betahemolytic streptococci; and (iii) antibodies to these antigens are present in high titers in patients with acute rheumatic fever. Our data suggest that passive hemagglutination antigens may be distinct from those extracellular enzymes and hemolysins ordinarily employed in streptococcal serological studies.
During the course of human infection, group A streptococci elaborate a variety of extracellular products (ECP), many of which are antigenic (3, 5) . Only a few of these ECP antigens are characterized precisely enough to allow their use in antibody tests for clinical and basic immunological purposes. Conventionally, the serodiagnosis of streptococcal infection is based upon titration of antibodies that neutralize the enzymatic or hemolytic activities of streptococcal extracellular antigens. Tests 
MATERIALS AND METHODS
Bacterial strains. Group A streptococcus, strain C203S, has been used extensively in many laboratories and is known to be a good producer of streptolysin 0, DNase B, NADase, and streptokinase (3).
Strains B.P. (group C) and E.W. (group G) were isolated from the throats of patients with pharyngitis. Diplococcus pneumoniae, type 24, is a laboratory stock strain. The Streptococcus viridans strain used in this study was isolated from the blood of a patient with subacute bacterial endocarditis.
Rabbit antisera. Bacteria were harvested after 18 h of growth in Todd-Hewitt broth at 37 C, washed twice with 0.9% NaCl, and adjusted to a turbidity of 100 U on a Klett-Summerson colorimeter (green filter). A 0.5-ml portion of the suspension of live organisms was injected intravenously into rabbits at zero time, and 1 ml was injected 3 days later. In some experiments a 1-ml booster injection was given during week 5 Antibody assays. The conventional streptococcal antibody tests were ASO, antihyaluronidase, ADNase B, antistreptokinase, and ANADase. Detailed protocols for the performance of these tests have been described elsewhere (3) . Assays for PHA antibodies were performed using streptozyme (STZ) reagent (Wampole Laboratories, Stamford, Conn.). The reagent consists of aldehyde-stabilized sheep red blood cells (RBC) sensitized with streptococcal ECP. ECP were obtained from modified Todd-Hewitt broth media by precipitation with ammonium sulfate at 60% saturation (information supplied by the manufacturer). The procedure for performance of this test in our laboratory has been published (2) .
Lots of STZ reagent employed were as follows: 2574, 121373, and 12573 were gifts of Wampole Laboratories; ST92, ST71, and ST70 were purchased commercially. In each PHA test, an ARF serum of known titer was included as a positive control, and saline was included as a negative control.
Affinity chromatography. This technique was carried out as described by Mannik and Stage (11) . Briefly, rabbit antiserum, obtained 7 days after immunization with live group A streptococci, was brought to 45% saturation with ammonium sulfate at 4 C. The resulting precipitate was redissolved in PBS, dialyzed against distilled water, and lyophilized. A 166-mg portion of the lyophilized material was dissolved in PBS and applied to a Sepharose 4-B cyanogen bromide-activated immunoadsorbent column (1 by 8 cm). The column was thoroughly washed, and 1 ml of 200 mg of ECP per ml from group A streptococcus was applied. The ECP preparation employed contained streptolysin 0, 31,024 U/ ml; DNase B, ¢1,024 U/ml; NADase, streptokinase, and hyaluronidase, <50 U/ml. After the immunoadsorbent column was washed with 60 ml of borate buffer (pH 8.4), antigen(s) that remained attached was eluted with 0.1 M glycine-hydrochloride buffer (pH 2.8). Fractions (1 ml) collected when the effluent reached pH 2.8 were pooled, dialyzed, and lyophilized. This material was designated "affinity chromatography fraction" (ACF).
Sensitization of RBC. Serial dilutions of streptococcal ECP and of ACF in saline were used to sensitize glutaraldehyde-fixed sheep erythrocytes (7). Sensitized RBC were tested against a 1:100 dilution of acute-phase serum from a patient with ARF. The minimum concentrations of ECP and ACF necessary for promoting passive hemagglutination under these conditions were determined.
Absorption of PHA antibody. Twenty microliters of ECP, ACF, or eluates from polyacrylamide gel sections of ACF were incubated for 30 min at 37 C with an equal volume of human or rabbit serum of known antistreptozyme (A-STZ) titer. Twofold dilutions (final volume, 20 ILI) were then prepared from the mixture to determine the antibody titer by the STZ test. A control consisting of saline without antigen was always included.
In other experiments, 0.5 ml of rabbit or human serum was absorbed with packed RBC obtained by centrifuging 1 ml of STZ reagent. Controls consisted of unsensitized, glutaraldehyde-fixed sheep RBC. After incubation at 37 C for 30 min, the mixture was centrifuged and the supernatant was separated for antibody assay. Antigenic activity. Serial dilutions of ECP or ACF were used to absorb A-STZ antibodies from an ARF serum. Conditions of absorption were identical to those described above. The ARF serum had an A-STZ titer of 1:1,600 and was employed at a dilution of 1:100 in these experiments. Antigenic activity was defined as the minimum amount of antigen (in micrograms) that completely inhibited agglutination.
2-ME. A 20-,ul portion of 0.03 M 2-mercaptoethanol (2-ME) was mixed with an equal volume of rabbit antiserum for 30 min at 37 C to inactivate immunogobulin M (IgM) antibody. The mixture was then further diluted to determine antibody titer in the STZ test.
Trypsin digestion. A 20-M1 portion of ACF (2 mg/ ml) was incubated with an equal volume of 1% trypsin (Difco) in PBS (pH 7.8) for 2 h at 37 C. Lima bean trypsin inhibitor (Difco) was then added, and the antigenic activity of the mixture was assayed as described above. Controls containing PBS without trypsin were included.
Polyacrylamide gel electrophoresis. Polyacrylamide gel electrophoresis was done by the method of Davis (4) . A 50-,ul portion of ACF (1.5 mg/ml) or ECP (200 mg/ml) from group A streptococcus was loaded on the gels. After termination ofelectrophoresis, the gels were cut into 3-mm sections; each section was extracted with 0.5 ml of saline for 24 h at 4 C. The eluates were separated, dialyzed against PBS, and tested for antigenic activity.
RESULTS
Immune response induced in rabbits injected with live streptococci. Intravenous injection of live beta-hemolytic streptococci (groups A, C, and G) induced appreciable immune responses, as measured by PHA using STZ reagent (Table 1) , whereas alpha-hemolytic streptococci (S. viridans and S. pneumoniae) failed to induce any detectable A-STZ response. Intravenous administration of several strains of heat-killed group A streptococci and intramuscular immunization with Todd-Hewitt broth in complete Freund adjuvant likewise failed to elicit PHA antibodies.
The dynamics of the immune response are illustrated by data from rabbit no. 160 (Fig. 1,  Table 2 ). A-STZ antibodies were detectable as early as 1 week after immunization and reached a peak titer of 1:600 by day 12 after immunization. In contrast, antibodies measured by the five conventional streptococcal antibody tests were not detected until 3 or more weeks after immunization. A-STZ titers of early bleedings were markedly reduced by ME treat- electrophoresis, sections of 3-mm thickness were prepared and eluted with buffer, and the eluates were used to absorb an ARF serum with a high titer of A-STZ antibodies. The absorbing activity of the eluates from the polyacrylamide sections was evident in three regions of the gel (Fig. 2) . Thus, the ARF serum contained hemagglutinating antibodies directed against three seroreactive ACF antigens that differ in their physiochemical properties. Similarly, when whole ECP was fractionated in polyacrylamide gel, the same three seroreactive regions were identified.
DISCUSSION
In the present study a fraction (ACF) ofgroup A streptococcal ECP was prepared. The ECP in this fraction were antigenically highly active in PHA reactions and in absorbing PHA antibodies from high-titered human sera. Several lines of evidence indicate that ACF antigens are distinct from those antigens ordinarily employed in streptococcal serological tests: (i) the immunoglobulins used to prepare ACF by affinity chromatography were devoid of any antibodies detectable by the five conventional antibody tests; (ii) ACF itself was devoid of any streptolysin 0 or DNase B activity, although these antigens were present in high titer in the ECP preparation from which it was derived; (iii) ACF failed to absorb ASO or ADNase B from ARF serum. It is possible, however, that our inability to detect these "conventional" extracellular antigens or antibodies to them may relate to differences in the sensitivity of the respective neutralization and hemagglutination antibody tests employed.
ACF appears to contain at least three immunoreactive antigens, as judged by the results of polyacrylamide gel fractionation experiments. Since these antigens were harvested from crude streptococcal broth supernates and since they are not yet adequately characterized, it is not certain that they are, indeed, extracellular in nature. Certainly, cellular antigens may be elaborated into the environment in considerable concentrations when streptococci are actively growing in vitro or in vivo.
Since (8) have recently reported that, after immunization of rabbits with relatively purified preparations of streptolysin 0 and DNase B, A-STZ titers peak prior to titers of ASO and ADNase B. In agreement with our findings, these authors reported that early-appearing A-STZ antibodies were predominantly IgM, an immunoglobulin known to participate avidly in agglutination reactions.
Ofek et al. (12) found evidence that A-STZ titers rose earlier than titers of conventional streptococcal antibodies in children with streptococcal pharyngitis. The data, though limited, suggested a rise in A-STZ titers in sera collected between days 6 and 9 after onset of sore throat. It is possible, therefore, that PHA antibody responses to certain streptococcal ECP, such as ACF, may provide serological evidence of streptococcal infections earlier in convalescence than do the conventional antibody neutralization tests.
Inquiry into the possible immunopathological significance of PHA antigens must await more precise immunochemical characterization. Nevertheless, these antigens are of considerable interest because: (i) they elicit a prompt and highly consistent immune response in humans and experimental animals; (ii) they appear thus far to be specific for beta-hemolytic streptococci; and (iii) antibodies to these antigens are present in high titers in patients with rheumatic fever and AGN (2) . Our data suggest that these antigens may well be distinct from those extracellular enzymes and hemolysins ordinarily employed in streptococcal serological studies.
